Compare ARK Genomic Revolution ETF (ARKG) vs Orion Office REIT Inc (ONL) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Orion Office REIT Inc — how do they compare? ARK Genomic Revolution ETF trades at $40.83, while Orion Office REIT Inc trades at $2.7 (market cap $156.28M). The key difference: Orion Office REIT Inc pays a 2.91% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Orion Office REIT Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | ONL | |
|---|---|---|
Sector | Sector/Thematic | Real Estate |
52-Week High | $43.57 | $3.04 |
52-Week Low | $23.09 | $1.93 |
Market Cap | — | $156.28M |
Enterprise Value | — | $639.94M |
Dividend Yield | — | 2.91% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
ONL trades at $2.75, down 1.08% on the day, with a neutral technical signal and bearish moving averages. The company reported a net loss of $139.31 million in 2025, with revenue declining to $147.65 million. Despite negative profitability, the stock trades at a low price-to-book ratio of 0.26 and recently announced a $0.02 dividend. Strategic reviews and portfolio repositioning are ongoing, as noted in recent earnings calls (Business Wire, 2026-05-07).
Outlook remains challenged by persistent losses and high debt, but strategic asset sales and refinancing improvements offer potential stabilization. Risks include further revenue declines and office sector headwinds, while analyst sentiment is evenly split between buy and hold ratings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Orion Office REIT Inc
Orion Office REIT Inc is a internally-managed REIT engaged in the ownership, acquisition, and management of a diversified portfolio of mission-critical and headquarters office buildings located in high quality suburban markets across the U.S. and leased primarily on a single-tenant net lease basis to creditworthy clients.
Read more on ONL →
